Cargando…
Exploring Toxins for Hunting SARS-CoV-2 Main Protease Inhibitors: Molecular Docking, Molecular Dynamics, Pharmacokinetic Properties, and Reactome Study
The main protease (M(pro)) is a potential druggable target in SARS-CoV-2 replication. Herein, an in silico study was conducted to mine for M(pro) inhibitors from toxin sources. A toxin and toxin-target database (T3DB) was virtually screened for inhibitor activity towards the M(pro) enzyme utilizing...
Autores principales: | Ibrahim, Mahmoud A. A., Abdelrahman, Alaa H. M., Jaragh-Alhadad, Laila A., Atia, Mohamed A. M., Alzahrani, Othman R., Ahmed, Muhammad Naeem, Moustafa, Moustafa Sherief, Soliman, Mahmoud E. S., Shawky, Ahmed M., Paré, Paul W., Hegazy, Mohamed-Elamir F., Sidhom, Peter A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875976/ https://www.ncbi.nlm.nih.gov/pubmed/35215266 http://dx.doi.org/10.3390/ph15020153 |
Ejemplares similares
-
Exploring Natural Product Activity and Species Source Candidates for Hunting ABCB1 Transporter Inhibitors: An In Silico Drug Discovery Study
por: Ibrahim, Mahmoud A. A., et al.
Publicado: (2022) -
Chetomin, a SARS-CoV-2 3C-like Protease (3CL(pro)) Inhibitor: In Silico Screening, Enzyme Docking, Molecular Dynamics and Pharmacokinetics Analysis
por: Ibrahim, Mahmoud A. A., et al.
Publicado: (2023) -
SuperNatural inhibitors to reverse multidrug resistance emerged by ABCB1 transporter: Database mining, lipid-mediated molecular dynamics, and pharmacokinetics study
por: Ibrahim, Mahmoud A. A., et al.
Publicado: (2023) -
Non-β-Lactam Allosteric Inhibitors Target Methicillin-Resistant Staphylococcus aureus: An In Silico Drug Discovery Study
por: Ibrahim, Mahmoud A. A., et al.
Publicado: (2021) -
Naturally occurring plant-based anticancerous candidates as prospective ABCG2 inhibitors: an in silico drug discovery study
por: Ibrahim, Mahmoud A. A., et al.
Publicado: (2022)